Investors

Building the objective measurement layer for cognition.

RetinaTek combines task-evoked neurocognitive measurement, proprietary multimodal data products, and a disciplined path from research-use validation to future clinical and performance markets.

Request investor materials Review evidence
Moat
  • Exclusive HJF license to a foundational patent family.
  • Cognitively loaded multimodal architecture.
  • Structured session reports that preserve trial-level timing, signal quality, and audit metadata.
  • Planned IP around classifiers, platform equivalence, and reporting.
  • Trade-secret protection for model and threshold details.
In development

RETINA Clinical

Future clinician-supervised assessment and recovery-management workflows

A planned regulated pathway for objective cognitive measurement in clinical settings. Clinical diagnostic claims are subject to future validation and regulatory clearance.

Research-use platform

RETINA Research

Clinical research, endpoint development, and site partnerships

A research-facing pathway for evidence generation, usability work, data-quality validation, and multimodal neurocognitive endpoint development.

Non-diagnostic performance tracking

Cognitive Readiness

Executive health, human performance, defense, and longitudinal brain-health programs

A future-facing track for opt-in cognitive readiness, personal baselines, and performance education without disease labeling or diagnostic claims.

Diligence asset

Technical sophistication is visible in the generated data.

RetinaTek's reporting layer converts controlled BEAM sessions into structured, auditable review artifacts for scientific, regulatory, partner, and investor diligence.

Open example session AOpen example session B
Capability

Trial-level timing alignment

RETINA can preserve stimulus events, cue type, block context, saccadic timing, manual response timing, and validity indicators in a reviewable structure.

Capability

Multimodal quality context

Reports can pair gaze-derived measures with pupil windows, blink/data-quality signals, and structured behavioral codes instead of flattening the session into a single score.

Capability

Auditable export trail

Parser version, schema version, source integrity fields, and generated timestamps support diligence, repeatability, and controlled review workflows.

Why now

Brain health needs measurement infrastructure, not another generic AI dashboard.

  • Clinical, research, and performance programs need objective cognitive signal beyond symptoms and brief screens.
  • Integrated eye tracking and controlled stimulus environments make precise task-evoked measurement more practical.
  • Longitudinal brain-health programs need repeatable, non-diagnostic cognitive performance metrics.
  • Investors can underwrite a research and future clinical wedge while preserving platform-scale upside.

Milestone path

Targets for diligence, not clearance claims.

R61

Months 1-12

Device lock, FDA pre-submission, IRB, and healthy-volunteer pilots

Planned program milestone

R33

Months 13-48

Pivotal clinical enrollment, algorithm optimization, and regulatory evidence package

Planned program milestone

Adult 510(k)

Month 45 target

Initial adult filing target for aid in the assessment of concussion

Regulatory target, not clearance

Special 510(k)

Month 51 target

Longitudinal monitoring supplement target for aid in the management of concussion

Regulatory target, not clearance

Adolescent supplement

Month 54 target

Supplement target for ages 10-17 after adolescent validation

Regulatory target, not clearance